Quarterly report pursuant to Section 13 or 15(d)

Equity Compensation

v3.23.1
Equity Compensation
3 Months Ended
Apr. 01, 2023
Share-Based Payment Arrangement [Abstract]  
Equity Compensation Equity Compensation
2021 Omnibus Incentive Plan
The Company maintains its 2021 Omnibus Incentive Plan (the “Plan”) under which it grants stock-based awards to eligible directors, officers and employees in order to attract, retain and reward such individuals and strengthen the mutuality of interest between such individuals and the Company’s stockholders. The Plan allows the Company to issue and grant 15,125,000 shares.
The Company measures compensation expense for stock-based awards in accordance with ASC Topic 718, Compensation – Stock Compensation (“ASC 718”). During the three months ended April 1, 2023, the Company granted stock-based awards including restricted stock units (“RSUs”), performance-based restricted stock units (“PSUs”), and stock options under the Plan. The grant date fair value of RSUs are equal to the closing price of the Company’s common stock on either: (i) the date of grant; or (ii) the previous trading day, depending on the level of administration required. Forfeitures are recognized as they occur, any unvested RSUs or stock options are forfeited upon a “Termination of Service”, as defined in the Plan, or as otherwise provided in the applicable award agreement or determined by the Company’s Compensation Committee of the Board of Directors.
Restricted Stock Unit Grants
RSUs are subject to a vesting period between one and four years. RSU activity for the three months ended April 1, 2023 is as follows:
(dollar amounts in thousands, except share and per share data)

Three Months Ended April 1, 2023
RSUs Weighted-Average Grant Date Fair Value
Unvested, outstanding at December 31, 2022
465,064  $ 10.5 
Granted 495,631  10.6 
Vested (58,790) 9.5 
Forfeited (9,288) 10.0 
Unvested, outstanding at April 1, 2023
892,617  $ 10.6 

Stock-based compensation expense for RSUs is recognized straight line over the respective service period, reduced for actual forfeitures, and included in general and administrative expense in the accompanying Unaudited Condensed Consolidated Statement of Operations and Comprehensive Income. Total compensation expense related to the above awards was approximately $637 and $600 for the three months ended April 1, 2023 and April 2, 2022, respectively. As of April 1, 2023, there was an aggregate of $8,538 of unrecognized expense related to the RSUs granted, which the Company expects to amortize over a weighted-average period of 3.01 years.
Performance-based Restricted Stock Unit Grants
PSU awards are based on the satisfaction of the Company’s performance metrics. The number of PSUs that become earned can range between 0% and 200% of the original target number of PSUs awarded for the 2022 awards. PSUs are subject to a three-year performance cliff-vesting period.
As of April 1, 2023, PSUs activity for the three months ended April 1, 2023 is as follows:
(dollar amounts in thousands, except share and per share data)
Three Months Ended April 1, 2023
PSUs Weighted-Average Grant Date Fair Value
Unvested, outstanding at December 31, 2022
252,923  $ 9.5 
Granted 229,091  10.6 
Vested —  — 
Forfeited —  — 
Unvested, outstanding at April 1, 2023 (1)
482,014  10.0 
1) This number excludes 252,923 performance stock units, which represents the incremental number of units that would be issued based on performance results from previously-granted PSU awards. The PSUs granted in 2022 are currently estimated at 200% of target.
Stock-based compensation expense for PSUs is recognized straight line over the requisite service period, reduced for actual forfeitures, and included in general and administrative in the accompanying Condensed Consolidated Statement of Operations and Comprehensive Income. Total compensation expense related to the PSUs was approximately $994 for the three months ended April 1, 2023. As of April 1, 2023, there
was an aggregate of $4,802 of unrecognized expense related to the PSUs granted, which the Company expects to amortize over a weighted-average period of 2.21 years.     
The above table represents PSUs assuming 100% of target payout at the time of the grant. Actual payouts can range between 0% and 200%, depending on performance results for the three-year performance period. As of April 1, 2023, the Company deemed the estimate of the PSUs granted in fiscal year ended December 31, 2022 to be issued at 200% of target, and have reflected such estimates within the share-based compensation expense. The Company estimates the PSU’s granted during the period ending April 1, 2023 to be issued at 100% of target.
The Actual payout of the 2022 grants will be in a range of 0% to 200%, depending on performance results for the three-year performance period from January 2, 2022, through December 28, 2024. The Actual payout of the 2023 grants will be in a range of 0% to 200%, depending on performance results for the three-year performance period from January 1, 2023, through December 27, 2025.

Stock Options
Stock options are granted by applying a valuation method to determine the grant date fair value for each stock option award. Stock options are subject to a vesting period of either three or four years. Stock option awards typically vest in 33% or 25% annual installments on each annual anniversary of the vesting commencement date for the duration of the vesting period, and expire ten years from the grant date. The fair value of each option is estimated using a Black-Scholes option valuation model using the independent valuations of the Company’s stock.
The principal assumptions utilized in valuing stock options include, the expected option life, the risk-free interest rate (an estimate based on the yield of United States Treasury zero coupon with a maturity equal to the expected life of the option), the expected stock price volatility using the historical and implied price volatility, and the expected dividend yield.
A summary of the assumptions used in determining the fair value of stock options is as follows:
(dollar amounts in thousands, except share and per share data)

Three Months Ended April 1, 2023
Expected life of option (years)
6.00 - 6.25
Risk-free interest rate
2.9% - 3.7%
Expected volatility of the Company’s stock
45% - 48%
Expected dividend yield on the Company’s stock —  %
Stock option activity for the three months ended April 1, 2023 is as follows:

Three Months Ended April 1, 2023
Stock Options Weighted-Average Grant Date Fair Value Weighted Average Remaining Contractual Life (in years) Intrinsic value
Unvested, outstanding at December 31, 2022
700,729  $ 4.5  9.8 $ 0.2 
Granted 18,796  5.3  10.0 — 
Exercised —  —  —  — 
Vested (113,252) 4.5  9.0 — 
Forfeited —  —  —  — 
Unvested, outstanding at April 1, 2023
606,273  $ 4.5  9.1 $ — 
Vested not exercised at April 1, 2023
113,252  $ 4.5  9.0 $ — 
Stock-based compensation expense for stock options is recognized straight line over the respective vesting period, reduced for actual forfeitures, and included in general and administrative expense in the accompanying Unaudited Condensed Consolidated Statement of Operations and Comprehensive Income. Total compensation expense related to stock options was approximately $199 and $— for the three months ended April 1, 2023 and April 2, 2022, respectively. Total unamortized stock-based compensation expense related to the unvested stock options was approximately $2,544, which the Company expects to amortize over a weighted-average period of 3.09 years.